Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;20(7):882-9.
doi: 10.5588/ijtld.15.0696.

Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe

J Z Metcalfe  1 , S Makumbirofa  2 , B Makamure  2 , C Sandy  3 , W Bara  4 , P Mason  5 , P C Hopewell  1
Affiliations

Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe

J Z Metcalfe et al. Int J Tuberc Lung Dis. 2016 Jul.

Abstract

Background: Patients at elevated risk of drug-resistant tuberculosis (TB) are prioritized for Xpert(®) MTB/RIF testing; however, the clinical usefulness of the test in this population is understudied.

Design: From November 2011 to June 2014, consecutive out-patients with a history of previous TB in high-density suburbs of Harare, Zimbabwe, were tested using Xpert, solid and liquid culture, and the microscopic observation drug susceptibility assay. Diagnostic accuracy for rifampin (RMP) resistance and time to initiation of second-line regimens were ascertained. The rpoB gene was sequenced in cases with culture-confirmed RMP resistance and genotypic susceptibility.

Results: Among 352 retreatment patients, 71 (20%) were RMP-resistant, 98 (28%) RMP-susceptible, 64 (18%) culture-negative/Xpert-positive, and 119 (34%) culture-negative/Xpert-negative. Xpert had a sensitivity of 86% (95%CI 75-93) and a specificity of 98% (95%CI 92-100) for RMP-resistant TB. The positive predictive value of Xpert-determined RMP resistance for multidrug-resistant TB (MDR-TB) was 82% (95%CI 70-91). Of 71 (83%) participants, 59 initiated treatment with second-line drugs, with a median time to treatment initiation of 18 days (IQR 10-44).

Conclusion: The diagnostic accuracy of Xpert for RMP resistance is high, although the predictive value for MDR-TB was lower than anticipated. Xpert allows for faster initiation of second-line treatment than culture-based drug susceptibility testing under programmatic conditions.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Screening and Analysis of the Study Population
*Includes patients diagnosed with both Xpert and phenotypic DST (n=54, 76%), DST only (n=9, 13%), and Xpert only (n=8, 11%).
Figure 2
Figure 2. Diagnostic Classification According to Retreatment Category
Cx-/GX-: culture-negative/Xpert-negative; Cx-/GX+: culture-negative/Xpert-positive; RIF: rifampin
Figure 3
Figure 3. Time to treatment initiation for patients with rifampin-resistant TB
See this image and copyright information in PMC

References

    1. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158–163. - PMC - PubMed
    1. Martinez D, Heudebert G, Seas C, et al. Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis. PLoS One. 2010;5(8):e12082. - PMC - PubMed
    1. Espinal MA, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis. 2001;5(10):887–893. - PubMed
    1. World Health Organization. [November 19, 2014];Global Tuberculosis Report 2014. Accessed at http://www.who.int/tb/publications/global_report/en/
    1. WHO, Xpert MTB/RIF implementation manual. [June 9, 2014];Technical and operational ‘how-to’: practical considerations. 2014 Apr; http://who.int/tb/laboratory/xpert_implem_manual/en/ - PubMed

Publication types

MeSH terms